The efficacy of immunotherapy combined with capecitabine versus immunotherapy alone as maintenance therapy in patients with de novo metastatic nasopharyngeal carcinoma: a retrospective propensity score matching study.

ESMO Open · 2025 · PMC12167090 · PMID 40466433

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

nearly significantP = 0.053so close (0.05 < p ≤ 0.1)

Similarly, Immu/Cape showed a nearly significant improvement in OS (median OS not reached versus not reached, P = 0.053; Figure 4 H).

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.